{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:23:19Z","timestamp":1761898999102,"version":"build-2065373602"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,10,10]],"date-time":"2017-10-10T00:00:00Z","timestamp":1507593600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Genetics"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.cancergen.2017.09.004","type":"journal-article","created":{"date-parts":[[2017,9,22]],"date-time":"2017-09-22T18:02:53Z","timestamp":1506103373000},"page":"51-57","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Correlations between microsatellite instability, ERCC1\/XRCC1 polymorphism and clinical characteristics, and FOLFOX adjuvant chemotherapy effect of colorectal cancer patients"],"prefix":"10.1016","volume":"218-219","author":[{"given":"Liping","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiangman","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinjiang","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guogang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijiang","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergen.2017.09.004_bib0010","first-page":"177","article-title":"Colorectal cancer statistics, 2017","volume":"67","author":"Siegel","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.cancergen.2017.09.004_bib0015","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/bjs.5328","article-title":"Microsatellite instability in colorectal cancer","volume":"93","author":"S\u00f6reide","year":"2006","journal-title":"Br J Surg"},{"key":"10.1016\/j.cancergen.2017.09.004_bib0020","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nature11252","article-title":"Comprehensive molecular characterization of human colon and rectal cancer","volume":"487","author":"Cancer Genome Atlas Network","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.cancergen.2017.09.004_bib0025","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/nm.3174","article-title":"Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions","volume":"19","author":"De Sousa","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.cancergen.2017.09.004_bib0030","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1038\/nm.3967","article-title":"The consensus molecular subtypes of colorectal cancer","volume":"21","author":"Guinney","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.cancergen.2017.09.004_bib0035","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrclinonc.2009.237","article-title":"Microsatellite instability in colorectal cancer-the stable evidence","volume":"7","author":"Vilar","year":"2010","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.cancergen.2017.09.004_bib0040","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1200\/JCO.2004.05.113","article-title":"FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study","volume":"22","author":"Tournigand","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cancergen.2017.09.004_bib0045","first-page":"4297","article-title":"Prognostic impact of microsatellite instability in colorectal cancer patients treated with adjuvant FOLFOX","volume":"30","author":"Des Guetz","year":"2010","journal-title":"Anticancer Res"},{"key":"10.1016\/j.cancergen.2017.09.004_bib0050","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1056\/NEJMoa022289","article-title":"Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer","volume":"349","author":"Ribic","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cancergen.2017.09.004_bib0055","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1136\/gut.2005.073015","article-title":"Mismatch repair status in the prediction of benefit from adjuvant fluorouracil chemotherapy in colorectal cancer","volume":"55","author":"Jover","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.cancergen.2017.09.004_bib0060","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1023\/A:1008213732429","article-title":"Oxaliplatin: a review of preclinical and clinical studies","volume":"9","author":"Raymond","year":"1998","journal-title":"Ann Oncol"},{"key":"10.1016\/j.cancergen.2017.09.004_bib0065","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.critrevonc.2004.08.008","article-title":"Recognition and processing of cisplatin- and oxaliplatin-DNA adducts","volume":"53","author":"Chaney","year":"2005","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.cancergen.2017.09.004_bib0070","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3109\/07357907.2012.716468","article-title":"Genetic polymorphism of XRCC1 correlated with response to oxaliplatin-based chemotherapy in advanced colorectal cancer","volume":"31","author":"Lv","year":"2013","journal-title":"Cancer Invest"},{"key":"10.1016\/j.cancergen.2017.09.004_bib0075","doi-asserted-by":"crossref","first-page":"425","DOI":"10.7150\/jca.8594","article-title":"ERCC1, XRCC1 and GSTP1 single nucleotide polymorphisms and survival of patients with colon cancer receiving oxaliplatin-based adjuvant chemotherapy","volume":"5","author":"Zaanan","year":"2014","journal-title":"J Cancer"},{"key":"10.1016\/j.cancergen.2017.09.004_bib0080","doi-asserted-by":"crossref","first-page":"8332","DOI":"10.1158\/1078-0432.CCR-05-1030","article-title":"Microsatellite instability and colorectal cancer prognosis","volume":"11","author":"Benatti","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cancergen.2017.09.004_bib0085","first-page":"2196703","article-title":"Low level of microsatellite instability correlates with poor clinical prognosis in stage ii colorectal cancer patients","volume":"2016","author":"Nazemalhosseini Mojarad","year":"2016","journal-title":"J Oncol"},{"key":"10.1016\/j.cancergen.2017.09.004_bib0090","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00384-006-0131-8","article-title":"Microsatellite instability did not predict individual survival of unselected patients with colorectal cancer","volume":"22","author":"Lamberti","year":"2007","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.cancergen.2017.09.004_bib0095","first-page":"241","article-title":"Prognostic and predictive relevance of microsatellite instability in colorectal cancer","volume":"14","author":"Storojeva","year":"2005","journal-title":"Oncol Rep"},{"key":"10.1016\/j.cancergen.2017.09.004_bib0100","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1158\/1055-9965.EPI-14-0533","article-title":"Family history of colorectal cancer is not associated with colorectal cancer survival regardless of microsatellite instability status","volume":"23","author":"Phipps","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.cancergen.2017.09.004_bib0105","doi-asserted-by":"crossref","first-page":"5313","DOI":"10.1200\/JCO.2006.08.2644","article-title":"ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer","volume":"24","author":"Locker","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cancergen.2017.09.004_bib0110","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1002\/ijc.28384","article-title":"Tumor markers in colorectal cancer, gastric cancer and gastrointestinal stromal cancers: European group on tumor markers 2014 guidelines update","volume":"134","author":"Duffy","year":"2014","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cancergen.2017.09.004_bib0115","first-page":"162","article-title":"ERCC1 gene polymorphism as a predictor for clinical outcome in advanced colorectal cancer patients treated with platinum-based chemotherapy","volume":"1","author":"Park","year":"2003","journal-title":"Clin Adv Hematol Oncol"},{"key":"10.1016\/j.cancergen.2017.09.004_bib0120","first-page":"3075","article-title":"A polymorphism of the XRCC1 gene predicts for response to platinum based treatment in advanced colorectal cancer","volume":"21","author":"Stoehlmacher","year":"2001","journal-title":"Anticancer Res"}],"container-title":["Cancer Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776217302351?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776217302351?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:41:37Z","timestamp":1761896497000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210776217302351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":23,"alternative-id":["S2210776217302351"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergen.2017.09.004","relation":{},"ISSN":["2210-7762"],"issn-type":[{"type":"print","value":"2210-7762"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correlations between microsatellite instability, ERCC1\/XRCC1 polymorphism and clinical characteristics, and FOLFOX adjuvant chemotherapy effect of colorectal cancer patients","name":"articletitle","label":"Article Title"},{"value":"Cancer Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cancergen.2017.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}